200 related articles for article (PubMed ID: 30976740)
1. Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
Jun T; Hsu YC; Ogawa S; Huang YT; Yeh ML; Tseng CH; Huang CF; Tai CM; Dai CY; Huang JF; Chuang WL; Yu ML; Tanaka Y; Nguyen MH
Hepatol Commun; 2019 Apr; 3(4):493-503. PubMed ID: 30976740
[TBL] [Abstract][Full Text] [Related]
2. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract][Full Text] [Related]
3. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
4. High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.
Shinkai N; Nojima M; Iio E; Matsunami K; Toyoda H; Murakami S; Inoue T; Ogawa S; Kumada T; Tanaka Y
J Gastroenterol; 2018 Jul; 53(7):883-889. PubMed ID: 29288305
[TBL] [Abstract][Full Text] [Related]
5. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Eur Radiol; 2022 Jul; 32(7):5016-5023. PubMed ID: 35142900
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
[TBL] [Abstract][Full Text] [Related]
7. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
[TBL] [Abstract][Full Text] [Related]
8. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
[TBL] [Abstract][Full Text] [Related]
9. Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis.
Chen CH; Wang JH; Lai HC; Hu TH; Hung CH; Lu SN; Peng CY
Am J Cancer Res; 2024; 14(5):2465-2477. PubMed ID: 38859836
[TBL] [Abstract][Full Text] [Related]
10. A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy.
Chen CH; Hu TH; Wang JH; Lai HC; Hung CH; Lu SN; Peng CY
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291847
[TBL] [Abstract][Full Text] [Related]
11. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
12. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
Tseng TC; Peng CY; Hsu YC; Su TH; Wang CC; Liu CJ; Yang HC; Yang WT; Lin CH; Yu ML; Lai HC; Tanaka Y; Nguyen MH; Liu CH; Chen PJ; Chen DS; Kao JH
Liver Cancer; 2020 Apr; 9(2):207-220. PubMed ID: 32399434
[TBL] [Abstract][Full Text] [Related]
13. Mac-2-Binding Protein Glycosylation Isomer as a Novel Predictor of Hepatocellular Carcinoma Recurrence in Patients with Hepatitis C Virus Eradication.
Yugawa K; Maeda T; Nagata S; Sakai A; Edagawa M; Omine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
Ann Surg Oncol; 2022 Apr; 29(4):2711-2719. PubMed ID: 34729653
[TBL] [Abstract][Full Text] [Related]
14. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.
Murata A; Amano N; Sato S; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Genda T
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192084
[TBL] [Abstract][Full Text] [Related]
15. Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu YC; Jun T; Huang YT; Yeh ML; Lee CL; Ogawa S; Cho SH; Lin JT; Yu ML; Nguyen MH; Tanaka Y
Aliment Pharmacol Ther; 2018 Nov; 48(10):1128-1137. PubMed ID: 30306612
[TBL] [Abstract][Full Text] [Related]
16. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.
Nagata H; Nakagawa M; Nishimura-Sakurai Y; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Goto F; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Tojo N; Tohda S; Asahina Y; Watanabe M;
Hepatol Int; 2016 Nov; 10(6):956-964. PubMed ID: 27435935
[TBL] [Abstract][Full Text] [Related]
17. Baseline serum Mac-2 binding protein glycosylation isomer as a predictor of hepatocellular carcinoma in chronic hepatitis B patients: a systematic review and meta-analysis.
Witarto AP; Witarto BS; Pramudito SL; Putra AJE; Nurhadi GM; Maimunah U
Ann Gastroenterol; 2022; 35(6):627-639. PubMed ID: 36406974
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients.
Liu J; Hu HH; Lee MH; Korenaga M; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; Mizokami M; Chen CJ; Yang HI
Sci Rep; 2017 Oct; 7(1):14352. PubMed ID: 29085039
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.
Pham TTT; Ho DT; Nguyen T
World J Hepatol; 2020 May; 12(5):220-229. PubMed ID: 32547689
[TBL] [Abstract][Full Text] [Related]
20. Use of M2BPGi in HCC patients with TACE.
Tak KY; Jang B; Lee SK; Nam HC; Sung PS; Bae SH; Choi JY; Yoon SK; Jang JW
J Gastroenterol Hepatol; 2021 Oct; 36(10):2917-2924. PubMed ID: 34031909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
